Kim de Roode

Kim de Roode studied Molecular Life Sciences at Radboud University in Nijmegen. In 2021 she received her Master’s degree in the specialization Chemistry of Life. In December 2021 she started her PhD-project which aims to improve the therapeutic window of tumor-targeted radiopharmaceuticals and immunotherapies by implementing the inverse-electron demand Diels-Alder pyridazine elimination reaction. This PhD-project is a project of Tagworks Pharmaceuticals and is supervised by Sandra Heskamp.​